Documentos de Saavedra Hernández D. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Palabras Claves: "Monoclonal antibody"

Subtipo de publicación

Publisher

Clinical and Translational Immunology(1)

Frontiers in Public Health(1)

Immunotherapy(1)

Área temáticas

Enfermedades(3)

Farmacología y terapéutica(2)

Medicina y salud(1)

Microorganismos, hongos y algas(1)

Problemas sociales y servicios a grupos(1)

Área de conocimiento

Inmunología(2)

Medicina interna(1)

Objetivos de Desarrollo Sostenible

ODS 10: Reducción de las desigualdades(3)

ODS 17: Alianzas para lograr los objetivos(3)

ODS 3: Salud y bienestar(3)

Año de Publicación

Origen

Palabras Claves

CD6 molecule(1)

An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: Report of three cases

Abstract: In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the di

Palabras claves:

CD6 molecule, coronavirus 2, covid-19, cytokine-release syndrome, IL-6, Itolizumab, Monoclonal antibody, SARS-COV-2

Añe-Kouri A.L., Berrio J., Caballero A., Caballero J.A., Cepeda M., Cervantes J.B., Figueredo C., Filgueira L.M., Herrera C., Leon K., Lorenzo G., Lovelle O.A., Mazorra Z., Ramos M., Saavedra Hernández D., Sánchez N., Tania Crombet

Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario

Abstract: EGFR signaling is an important regulator of SARS-CoV induced lung damage, inflammation and fibrosis.

Palabras claves:

brief research report nimotuzumab, covid-19, eGFR, FIBROSIS, inflammation, Monoclonal antibody, SARS-COV-2

Batista D., Cabrera L., Diaz H., Domeq M., Gorte A., Hernández A., Hernández R., Jiménez J., Jova J.H., Luaces P.L.o., Martínez A., Medel L., Pérez Ruiz L., Porto L., Ramos M., Saavedra Hernández D., Sánchez L., Tania Crombet, Travieso N., Troche M., Valdés L., Valls A.R.

Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab

Abstract: Objectives: COVID-19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on matur

Palabras claves:

CD6, covid-19, Cytokine release syndrome, Itolizumab, Monoclonal antibody, SARS-COV2

Arencibia M., Betancourt J., Caballero A., Cabrera L., Castillo U., Cepeda M., Despaigne R.E., Diaz H., Domecq M., Escalona A., Estevez D., Filgueira L.M., García Y., Hidalgo C.J., Leon K., Lorenzo G., Lorenzo P., Martinez A., Mazorra Z., Meriño E., Ortega L.M., Ramírez A., Ramos M., Saavedra Hernández D., Sánchez L., Sánchez N., Tania Crombet, Valenzuela-Silva C.M.